Evidence map›Paper›PMID 33467670›Full record

ReviewInternational journal of molecular sciences2021

Spent Brewer's Yeast as a Source of Insoluble β-Glucans.

Ionut Avramia, Sonia Amariei

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Release of Biopolymers fromMicroorganisms · 2024
    Article
  9. Article
  10. Spent Brewer's Yeast Lysis Enables aInternational journal of molecular sciences · 2024
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Solid-StateMolecules (Basel, Switzerland) · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ionut AvramiaFaculty of Food Engineering, Stefan cel Mare University of Suceava, 720229 Suceava, Romania.ORCID 0000-0003-3409-6269
Sonia AmarieiFaculty of Food Engineering, Stefan cel Mare University of Suceava, 720229 Suceava, Romania.

Funding

Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii PN-III-P2-2.1-PED-2019-3863
6 · The paper itself

Abstract

In the brewing process, the consumption of resources and the amount of waste generated are high and due to a lot of organic compounds in waste-water, the capacity of natural regeneration of the environment is exceeded. Residual yeast, the second by-product of brewing is considered to have an important chemical composition. An approach with nutritional potential refers to the extraction of bioactive compounds from the yeast cell wall, such as β-glucans. Concerning the potential food applications with better textural characteristics, spent brewer's yeast glucan has high emulsion stability and water-holding capacity fitting best as a fat replacer in different food matrices. Few studies demonstrate the importance and nutritional role of β-glucans from brewer's yeast, and even less for spent brewer's yeast, due to additional steps in the extraction process. This review focuses on describing the process of obtaining insoluble β-glucans (particulate) from spent brewer's yeast and provides an insight into how a by-product from brewing can be converted to potential food applications.

Indexed as

Autolysisbeta-GlucansBreadCell NucleusCell WallCytokinesCytoplasmElastic ModulusFood IndustryFood SafetyFood TechnologyHydrogen-Ion ConcentrationOrganic ChemicalsPolysaccharidesSaccharomyces cerevisiaeSolubilitybeta-GlucansCytokinesOrganic ChemicalsPolysaccharidesWastewaterbioactive polysaccharidesparticulate β-glucansSaccharomyces cerevisiaespent brewer’s yeast

Identifiers

PMID33467670
PMCPMC7829969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.